What Merck Sharp & Dohme LLC pays H-1B Scientist Preclinical Developments
Merck Sharp & Dohme LLC filed 14 certified H-1B LCAs for Scientist Preclinical Development roles in FY2025-FY2026. In FY2026 (October to June), the middle half of its 5 filings stated $117,000 to $117,000 a year, with a median of $117,000.
By fiscal year
| Year | LCAs | Median | Middle half | Lowest to highest | Prevailing wage |
|---|---|---|---|---|---|
| FY2026 so far | 5 | $117,000 | $117,000 to $117,000 | $114,700 to $184,200 | $96,054 |
| FY2025 | 9 | $114,700 | $114,700 to $114,700 | $114,700 to $180,500 | $91,770 |
Prevailing wage is the median of the DOL prevailing wage on the same filings: the floor the law sets for that job and place.
By prevailing-wage level
| Level | LCAs | Median | Middle half |
|---|---|---|---|
| Level I (entry) | 1 | $114,700 | too few |
| Level II (qualified) | 9 | $114,700 | $114,700 to $114,700 |
| Level III (experienced) | 3 | $117,000 | too few |
| Level IV (fully competent) | 1 | $117,000 | too few |
Level I is entry and Level IV is fully competent, as the employer classified the position. Seniority words in the job title are folded into one title here; the level is where seniority shows.
By worksite
| Worksite | LCAs | Median | Lowest to highest |
|---|---|---|---|
| Rahway, NJ | 11 | $114,700 | $114,700 to $117,000 |
| West Point, PA | 3 | $117,000 | $114,700 to $117,000 |
Titles grouped here
- Senior Scientist, Preclinical Development (12)
- Sr. Scientist, Preclinical Development (2)
Filed as Biochemists and Biophysicists (SOC 19-1021).
Applying to Merck Sharp & Dohme LLC?
Nyanza puts these filings next to any Scientist Preclinical Development posting you check, so you know what the employer has stated before the first call.